Tokyo, Japan

Satofumi Kawata

This inventor holds 6 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Sbi Pharmaceuticals Co., Ltd., The University of Tokyo, Neopharma Japan Co., Ltd.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satofumi Kawata. Retrieved from https://idiyas.com/inventor/satofumi-kawata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Satofumi Kawata

Introduction

Satofumi Kawata is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing agents for preventing and treating various health conditions. With a total of five patents to his name, Kawata's work reflects a commitment to improving health outcomes through innovative solutions.

Latest Patents

Kawata's latest patents include an agent for preventing and/or treating veisalgia, aimed at providing a hangover prophylactic and therapeutic solution. This invention comprises 5-aminolevulinic acid (ALA) and its derivatives, which are designed to alleviate hangover symptoms effectively. Another significant patent focuses on an anemia of cancer improving and prophylactic agent. This method involves administering an agent containing ALA or its derivatives to ameliorate or prevent cancerous anemia, showcasing Kawata's dedication to addressing critical health issues.

Career Highlights

Throughout his career, Satofumi Kawata has worked with prominent organizations, including Sbi Pharmaceuticals Co., Ltd. and the University of Tokyo. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his innovative capabilities.

Collaborations

Kawata has collaborated with notable colleagues such as Tohru Tanaka and Motowo Nakajima. These partnerships have contributed to the development of his patents and the advancement of research in his areas of expertise.

Conclusion

Satofumi Kawata's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to inspire advancements in medical treatments and showcases the importance of innovation in addressing health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…